Author

Ismael El Hajra Martinez

ADALIMUMAB 80MG EVERY OTHER WEEK IN INFLAMMATORY BOWEL DISEASE: TREATMENT INTENSIFICATION OUTCOMES IN REAL LIFE CLINICAL PRACTICE
ADALIMUMAB 80MG EVERY OTHER WEEK IN INFLAMMATORY BOWEL DISEASE: TREATMENT INTENSIFICATION OUTCOMES IN REAL LIFE CLINICAL PRACTICE

Ismael El Hajra Martinez  et al.

IMPACT OF BIOLOGICAL AGENTS ON POSTOPERATIVE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE STUDY OF GETECCU
IMPACT OF BIOLOGICAL AGENTS ON POSTOPERATIVE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE STUDY OF GETECCU

Ismael El Hajra Martinez  et al.

Item 1 - 2 / 2
1